HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.950
-0.040 (-2.01%)
Apr 28, 2025, 4:00 PM EDT - Market closed
HeartBeam Employees
HeartBeam had 21 employees as of December 31, 2024. The number of employees increased by 6 or 40.00% compared to the previous year.
Employees
21
Change (1Y)
6
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$926,095
Market Cap
65.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | 6 | 40.00% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 10 | 200.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BEAT News
- 4 days ago - HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - Business Wire
- 6 weeks ago - HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - HeartBeam Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 7 weeks ago - HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 - Business Wire
- 2 months ago - HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time - Business Wire
- 2 months ago - HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock - Business Wire
- 2 months ago - HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock - Business Wire
- 3 months ago - HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software - Business Wire